Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DK

Daniel James Koch — 9 Patents

Eli Lilly: 9 patents #393 of 2,858Top 15%
Indianapolis, IN: #676 of 5,011 inventorsTop 15%
Indiana: #4,123 of 33,936 inventorsTop 15%
Overall (All Time): #535,341 of 4,157,543Top 15%
9 Patents All Time
Daniel James Koch has been granted 9 US patents while listed as an inventor at Eli Lilly. The first was granted in 1998 and the most recent in December 2006. Daniel James Koch ranks #535,341 of 4,157,543 US inventors in our database (top 12.9%). Patent records list Daniel James Koch in Indianapolis, IN, US.

Patents per Year

Patents granted per year, 1998 to 2006Bar chart with a peak of 2 patents in 1998.peak 21998: 2 patents19981999: 2 patents19992000: 1 patents20002001: 2 patents20012002: 1 patents20022006: 1 patents2006

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7144898 Indole derivatives for the treatment of depression and anxiety Marvin M. Hansen, John Xiaoqiang He, Nicholas Allan Honigschmidt, Todd J. Kohn, Vincent Patrick Rocco +2 more 2006-12-05 $65,374,000
6358972 5-HT1F agonists Sandra Ann Filla, Brian Michael Mathes, Vincent Patrick Rocco 2002-03-19 $63,225,000
6303627 Inhibitors of serotonin reuptake Vincent Patrick Rocco 2001-10-16 $145,417,000
6242450 5-HT1F antagonists Lee A. Phebus, Vincent Patrick Rocco, Tammy Joy Sajdyk 2001-06-05 $240,697,000
6046215 Inhibition of serotonin reuptake James E. Audia, Thomas E. Mabry, Jeffrey S. Nissen, Vincent Patrick Rocco, Yao-Chang Xu 2000-04-04 $216,653,000
5962474 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1h-indoles: 5-HT.sub.1F agonists James E. Audia, Bruce A. Dressman, James J. Droste, James E. Fritz, Stephen W. Kaldor +5 more 1999-10-05 $103,905,000
5912256 Compounds having effects on serotonin-related systems Vincent Patrick Rocco 1999-06-15 $153,165,000
5846982 Inhibition of serotonin reuptake James E. Audia, Thomas E. Mabry, Jeffrey S. Nissen, Vincent Patrick Rocco, Yao-Chang Xu 1998-12-08 $178,932,000
5708008 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1H-indoles: new 5-HT.sub.1F agonists James E. Audia, Bruce A. Dressman, James J. Droste, James E. Fritz, Stephen W. Kaldor +5 more 1998-01-13 $65,836,000